ArticleJACC. Advances2025

Early Access to Tafamidis for Patients With Transthyretin Amyloid Cardiomyopathy.

Maria G Crespo-Leiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.